论文部分内容阅读
目的:分析2型糖尿病餐后低血糖使用阿卡波糖治疗的临床疗效。方法:选取2014年12月至2015年6月到该院进行2型糖尿病餐后低血糖治疗患者60例,随机进行分组,其中对照组为30例,研究组为30例,给予对照组二甲双胍治疗方法,给予研究组阿卡波糖治疗方法,分析对比两组患者在治疗后低血糖发生率。结果:给予两组患者不同的药物治疗方法后,研究组的餐后在第一周、第二周、第三周以及第四周血糖发生率明显低于对照组。组间数据对比存在明显差异(P<0.05),具有统计学意义。结论:对2型糖尿病餐后低血糖患者采用阿卡波糖治疗方法,效果显著,餐后低血糖次数发生率明显降低,值得在临床医学上大力推广使用。
Objective: To analyze the clinical efficacy of acarbose in the treatment of postprandial hypoglycemia in type 2 diabetic patients. Methods: From December 2014 to June 2015, 60 patients with postprandial hypoglycemia of type 2 diabetes mellitus were enrolled in the hospital from December 2014 to June 2015. The patients in the control group were 30 cases, the study group was 30 cases and the control group metformin Methods The study group acarbose treatment, analysis and comparison of two groups of patients after treatment, the incidence of hypoglycemia. Results: After giving different medication methods to two groups of patients, the incidence of postprandial glycemia in the first week, the second week, the third week and the fourth week of the study group was significantly lower than that of the control group. There was significant difference between groups (P <0.05), with statistical significance. Conclusion: Acarbose treatment for postprandial hypoglycemia in type 2 diabetic patients is effective and the incidence of postprandial hypoglycemia is significantly reduced, which is worth to be widely used in clinical medicine.